Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial

Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial have?

Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial has 86 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial published?

Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial has 2020 year in the ScholarIQ index.

What is the open-access status of Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial?

Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial has closed oa status in the ScholarIQ index.

What is the DOI of Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial?

The DOI for Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial is on the source record.

What is the PMID of Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial?

The PMID for Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial is on the source record.

What is the OpenAlex record for Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial?

The OpenAlex for Efficacy and safety of dapagliflozin in acute heart failure: Rationale and design of the DICTATE-AHF trial is on the source record.